Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Khalid Islam Ph.D. | Executive Chairman | 75k | -- | 1955 |
| Mr. Gene Mack M.B.A. | President, CEO & Director | -- | -- | -- |
| Mr. Gianluca Fuggetta | Senior VP of Finance & Principal Financial Officer | -- | -- | 1989 |
| Dr. Joanne Taylor Ph.D. | Senior Vice President of Research | -- | -- | -- |
| Dr. Terenzio Ignoni Pharm.D. | Senior Vice President of Technical Operations | -- | -- | -- |
| Dr. Jonas Hannestad M.D., Ph.D. | Chief Medical Officer | -- | -- | -- |
Gain Therapeutics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 23
Description
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate, GT-02287 for the treatment of GBA1 Parkinson's disease is being evaluated in a Phase I clinical trials. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of Dementia with Lewy Bodies, Alzhiemer's Disease, Gaucher, GM1 Gangliosidosis, Krabbe Disease, Alpha1-Antitrypsun deficiency, and solid tumors. The company was founded in 2017 and is headquartered in Bethesda, Maryland.
Corporate Governance
Upcoming Events
May 12, 2025 at 12:30 PM UTC - May 16, 2025 at 12:30 PM UTC
Gain Therapeutics, Inc. Earnings Date